.png)
Welcome to the official website of the National Medicine Regulatory Authority of Sri Lanka. We are dedicated to ensuring the safety and efficacy of medicines for the people of Sri Lanka.

The National Medicine Regulatory Authority of Sri Lanka is committed to ensuring the safety, efficacy, and quality of medicines in the country. We strive to protect public health by regulating the manufacturing, importation, distribution, and sale of medicines.


NMRA regulates medicines, medical devices, borderline products imported to and manufactured in Sri Lanka. We also regulate pharmacies. Clinical trials conducted in Sri Lanka are also regulated by us.
Find Out MoreNational Medicines Quality Assuarance of the NMRA is responsible for the analyzing of the quality of any medicine, medical device or borderline product forwarded by the Authority. It functions as an additional approved analyst when the circumstance so requires.
Find Out MorePharmacovigilance Division is responsible for monitoring and dealing with adverse drug reaction, quality failure and counterfeit medicines.
Find Out MoreInspectorate and Enforcement Division is responsible for inspecting and investigating issues pertaining to proper implementation of the provision of the NMRA Act.
Find Out MoreThe National Medicines Regulatory Authority hereby informs all medicine importers and local manufacturers in Sri Lanka that registration applications are accepted for the extended release formulations of Methylphenidate, Lisdexamfetamine and other related stimulant medicines used in the management of Attention Deficit Hyperactivity Disorder (ADHD).
All Marketing Authorization Holders of Cosmetics are hereby informed that acceptance of cosmetic dossiers will be conducted only on Wednesday, 18th February 2026, from 9.00 a.m. to 2.00 p.m.,due to unavoidable circumstances
Please make the necessary arrangements to submit your dossiers within the above specified date and time.